
Guardian Pharmacy Services Inc GRDN.N reported quarterly adjusted earnings of 15 cents per share for the quarter ended March 31. The mean expectation of two analysts for the quarter was for earnings of 18 cents per share.
Revenue was $329.31 million; analysts expected $321.21 million.
Guardian Pharmacy Services Inc's reported EPS for the quarter was 15 cents.
The company reported quarterly net income of $9.45 million.
Guardian Pharmacy Services Inc shares had risen by 20.6% this quarter and gained 26.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 5.9% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the drug retailers peer group is also "buy"
Wall Street's median 12-month price target for Guardian Pharmacy Services Inc is $25.00
This summary was machine generated from LSEG data May 12 at 09:56 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Mar. 31 2025 | 0.18 | 0.15 | Missed |
Dec. 31 2024 | 0.17 | 0.19 | Beat |
Sep. 30 2024 | 0.19 | -2.00 | Missed |